Information For The Package Leaflet
Found 4 free book(s)
Information for the package leaflet regarding polysorbates ...
www.ema.europa.euInformation for the package leaflet regarding p olysorbates used as excipients in medicinal products for human use EMA/CHMP/190743/2016 Page 6/42 : pressure, heart beat changes). studies show cardiac depression in dogs and inhibition of hERG currents by polysorbates in vitro. The potential for torsades de pointes in
PACKAGE LEAFLET: INFORMATION FOR THE USER Daktarin …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Daktarin® oral gel Miconazole Daktarin is a registered trademark Read all of this leaflet carefully before you start using this medicine. • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor or pharmacist • This medicine has been prescribed for you.
Package leaflet: Information for the user Comirnaty 10 ...
assets.publishing.service.gov.ukPackage leaflet: Information for the user Comirnaty 10 micrograms/dose concentrate for dispersion for injection Children 5 to 11 years COVID-19 mRNA Vaccine (nucleoside modified) tozinameran This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eunew safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT Comirnaty 30micrograms/dose concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION